Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.44% |
| 2 | Healthcare | 8.01% |
| 3 | Financials | 6.79% |
| 4 | Industrials | 6.22% |
| 5 | Consumer Discretionary | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLO
2726
DELISTED
Olo Inc
OLO
| $4.4M | ﹤0.01% |
996,486
+194,735
| +24% | +$922K |
|
2727
CALL
Madrigal Pharmaceuticals
MDGL
$11.4B
| $4.4M | ﹤0.01% |
15,700
+14,800
| +1,644% | +$3.52M |
|
2728
Ethan Allen Interiors
ETD
$583M
| $4.39M | ﹤0.01% |
157,480
+150,409
| +2,127% | +$4.46M |
|
2729
Adicet Bio
ACET
$84.7M
| $4.38M | ﹤0.01% |
226,354
-30,282
| -12% | -$811K |
|
2730
Oportun Financial
OPRT
$259M
| $4.37M | ﹤0.01% |
1,507,012
+314,553
| +26% | +$954K |
|
2731
Matthews International
MATW
$866M
| $4.36M | ﹤0.01% |
174,192
-11,188
| -6% | -$307K |
|
2732
Smith & Wesson
SWBI
$669M
| $4.35M | ﹤0.01% |
+303,648
| New | +$4.99M |
|
2733
Cricut
CRCT
$976M
| $4.35M | ﹤0.01% |
725,612
-428,990
| -37% | -$2.57M |
|
2734
CALL
Jacobs Solutions
J
$15.7B
| $4.34M | ﹤0.01% |
37,599
+17,167
| +84% | +$2.01M |
|
|
NOA
2735
North American Construction
NOA
$365M
| $4.34M | ﹤0.01% |
225,336
+159,142
| +240% | +$3.31M |
|
2736
Gorman-Rupp
GRC
$2.13B
| $4.34M | ﹤0.01% |
118,284
-88,186
| -43% | -$3.11M |
|
2737
PUT
Zimmer Biomet
ZBH
$18.4B
| $4.34M | ﹤0.01% |
40,000
+29,400
| +277% | +$3.47M |
|
2738
PUT
Raymond James Financial
RJF
$33.6B
| $4.34M | ﹤0.01% |
35,100
+28,000
| +394% | +$3.46M |
|
2739
PUT
Charles River Laboratories
CRL
$11.3B
| $4.34M | ﹤0.01% |
21,000
-63,700
| -75% | -$14.4M |
|
2740
Ibotta
IBTA
$614M
| $4.33M | ﹤0.01% |
+57,671
| New | +$5.37M |
|
2741
PUT
Sarepta Therapeutics
SRPT
$1.64B
| $4.33M | ﹤0.01% |
27,400
+7,900
| +41% | +$1.01M |
|
2742
Inspire Medical Systems
INSP
$1.44B
| $4.33M | ﹤0.01% |
32,326
+18,236
| +129% | +$3.45M |
|
2743
Supernus Pharmaceuticals
SUPN
$2.65B
| $4.32M | ﹤0.01% |
161,332
+128,743
| +395% | +$3.73M |
|
2744
Navient
NAVI
$794M
| $4.3M | ﹤0.01% |
295,592
+193,451
| +189% | +$2.99M |
|
2745
Standex International
SXI
$3.48B
| $4.3M | ﹤0.01% |
+26,676
| New | +$4.51M |
|
2746
Inhibrx
INBX
$1.24B
| $4.3M | ﹤0.01% |
+303,196
| New | +$4.74M |
|
2747
NatWest
NWG
$73.7B
| $4.3M | ﹤0.01% |
535,016
-103,097
| -16% | -$800K |
|
2748
LegalZoom.com
LZ
$1.35B
| $4.28M | ﹤0.01% |
509,748
+43,039
| +9% | +$443K |
|
|
KDK
2749
Kodiak AI
KDK
$815M
| $4.27M | ﹤0.01% |
400,000
| – | – |
|
2750
WesBanco
WSBC
$3.99B
| $4.27M | ﹤0.01% |
152,858
+125,883
| +467% | +$3.48M |
|
Similar funds
Millennium Management's Q2 2024 Portfolio in Review
As of Q2 2024, Millennium Management held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management withdrew a net $24.5B in Q2 2024, closing 995 positions and reducing 2,549 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $907M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in QXO Inc worth $20.6M.
- Millennium Management's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Millennium Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Millennium Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Millennium Management's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Millennium Management opened 661 new positions and closed 995 in Q2 2024.
- Millennium Management's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.